| EPC0465 | New modalities to fill gaps in new case finding among high-risk key populations during COVID-19 in Phnom Penh, Cambodia | E-poster | HIV testing |
| EPA0011 | Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice | E-poster | HIV pathogenesis |
| EPA0071 | NK cell-mediated viral control of SIV in sooty mangabey lymph nodes | E-poster | Understanding and targeting persistent HIV reservoirs |
| OAC0402 | No association between in-utero PrEP exposure and bone mineral density at 36 months of age among mother-infant pairs in Kenya | Oral abstract session with live Q&A | HIV prevention research |
| TUPEE21 | No data no more: a tool to end the exclusion of trans and gender-diverse people in HIV research | Poster exhibition | Innovations in data collection, monitoring and evaluation |
| EPA0099 | No impact of HIV status on COVID-19 vaccine responses in Botswana | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPC0518 | No impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron era | E-poster | Epidemiology of COVID-19 |
| EPE0770 | Non-reporting of intimate partner violence among index case testing clients: experience from Malawi | E-poster | Implementation science and scale up of HIV testing |
| MOPEA07 | Novel adjuvant ALFQ elicits a strong immune stimulatory signature that correlates with remarkable magnitude T cell and humoral immune responses following pox-protein vaccination | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| OAA0402 | Novel V1 deleted-envelope vaccine based on VLP protects against SHIV infection | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |